Global Animal Therapeutics and Diagnostics [Animal Therapeutic Products (Anti-Parasitic drugs and Antibiotics, Anti-inflammatory drugs, Anesthetics and Other Drugs), Animal Diagnostics Products (Instruments and Consumables)], Animal Type [Companion animals (Dogs, Cats, and Others), Cattle, Pigs, Poultry and Sheep] - Global Opportunity Analysis and Industry Forecast, 2014-2022

CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION

1.2. Key Benefits

1.3. Key Market Segments

1.4. Research Methodology

1.4.1. Secondary research

1.4.2. Primary research

1.4.3. Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. CXO Perspective

CHAPTER 3 MARKET OVERVIEW

3.1. Market definition and scope

3.2. Key findings

3.2.1. Top investment pockets

3.3. Government regulations

3.3.1. Center for Veterinary Medicine (CVM)

3.3.2. Environmental Protection Agency (EPA)

3.4. Patents Analysis

3.4.1. PATENT ANALYSIS BY YEAR

3.4.1.1. Patent analysis of animal therapeutics by year

3.4.1.2. Patent analysis of animal diagnostics by year

3.4.2. PATENT ANALYSIS BY REGION

3.4.2.1. Patent analysis of animal diagnostics by region

3.4.2.2. Patent analysis of animal diagnostics by region

3.5. Market dynamics

3.5.1. Drivers

3.5.1.1. Rising demand for animal derived food products

3.5.1.2. Growing demand for pet insurance

3.5.1.3. Rising concern to prevent zoonotic diseases

3.5.1.4. Growing ownership of companion animals

3.5.1.5. Rising animal health expenditure

3.5.2. Restraints

3.5.2.1. Highly competitive meat and milk prices

3.5.2.2. Lack of animal health awareness

3.5.2.3. Adverse impact of veterinary drugs on human and animal health

3.5.3. Opportunities

3.5.3.1. Advancement in therapeutic and diagnostic products

3.5.3.2. Therapeutic and diagnostic products for hybrid animals

CHAPTER 4 ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY PRODUCT TYPE

4.1. Overview

4.1.1. Market size and forecast

4.2. animal diagnostics products

4.2.1. Market size and forecast

4.2.2. Instruments

4.2.2.1. Key market trends

4.2.2.2. Key growth factors and opportunities

4.2.3. Consumables

4.2.3.1. Key market trends

4.2.3.2. Key growth factors and opportunities

4.3. animal therapeutics products

4.3.1. Market size and forecast

4.3.2. Anti-Parasitic drugs and antibiotics

4.3.2.1. Key market trends

4.3.2.2. Key growth factors and opportunities

4.3.3. Anti-Inflammatory drugs

4.3.3.1. Key market trends

4.3.3.2. Key growth factors and opportunities

4.3.4. Anesthetics

4.3.4.1. Key market trends

4.3.4.2. Key growth factors and opportunities

4.3.5. Others

4.3.5.1. Key market trends

4.3.5.2. Key growth factors and opportunities

CHAPTER 5 ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY ANIMAL TYPE

5.1. Overview

5.1.1. Market size and forecast

5.2. Companion Animals

5.2.1. Market size and forecast

5.2.2. Dogs

5.2.3. Cats

5.2.4. Other Companion Animals

5.3. Cattle

5.3.1. Market size and forecast

5.4. Pigs

5.4.1. Market size and forecast

5.5. Poultry

5.5.1. Market size and forecast

5.6. Sheep

5.6.1. Market size and forecast

CHAPTER 6 ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY GEOGRAPHY

6.1. Overview

6.1.1. Market size and forecast

6.2. North America

6.2.1. Key market trends

6.2.2. Key growth factors and opportunities

6.2.3. Market size and forecast

6.2.4. U.S. market size & forecast

6.2.5. Canada market size and forecast

6.2.6. Mexico market size and forecast

6.3. Europe

6.3.1. Key market trends

6.3.2. Key growth factors and opportunities

6.3.3. Market size and forecast

6.3.4. Germany market size and forecast

6.3.5. France market size and forecast

6.3.6. UK market size and forecast

6.3.7. Italy market size and forecast

6.3.8. Rest of Europe market size and forecast

6.4. Asia-Pacific

6.4.1. Key market trends

6.4.2. Key growth factors and opportunities

6.4.3. Market size and forecast

6.4.4. Japan market size and forecast

6.4.5. China market size and forecast

6.4.6. Australia market size and forecast

6.4.7. India market size and forecast

6.4.8. South Korea market size and forecast

6.4.9. Taiwan market size and forecast

6.4.10. Rest of Asia-Pacific market size and forecast

6.5. LAMEA

6.5.1. Key market trends

6.5.2. Key growth factors and opportunities

6.5.3. Market size and forecast

6.5.4. Brazil market size and forecast

6.5.5. Turkey market size and forecast

6.5.6. Venezuela market size and forecast

6.5.7. Saudi Arabia market size and forecast

6.5.8. Rest of LAMEA market size and forecast

CHAPTER 7 COMPANY PROFILES

7.1. Bayer AG

7.1.1. Company overview

7.1.2. Operating business segments

7.1.3. Business performance

7.1.4. Key strategic moves & developments

7.2. Eli Lilly and Company

7.2.1. Company overview

7.2.2. Operating business segments

7.2.3. Business performance

7.2.4. Key strategic moves & developments

7.3. Boehringer, Ingelheim GmbH

7.3.1. Company overview

7.3.2. Operating business segments

7.3.3. Business performance

7.4. Merck & Co.

7.4.1. Company overview

7.4.2. Business performance

7.4.3. Key strategic moves & developments

7.5. Zoetis Inc.

7.5.1. Company overview

7.5.2. Operating business segments

7.5.3. Business performance

7.6. Ceva Sant Animale

7.6.1. Company overview

7.6.2. Operating business segments

7.6.3. Business performance

7.7. Sanofi S.A.

7.7.1. Company overview

7.7.2. Operating business segments

7.7.3. Business performance

7.7.4. Key strategic moves & developments

7.8. Nutreco N.V.

7.8.1. Company overview

7.8.2. Operating business segments

7.8.3. Business performance

7.9. Virbac S.A.

7.9.1. Company overview

7.9.2. Business performance

7.9.3. Key strategic moves & development

*Details on financial performance, strategic moves and developments may not be captured for unlisted companies.

*Please note this is a tentative TOC and may change with research proceedings.

LIST OF TABLES

TABLE 1. GLOBAL ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY PRODUCT ($ MILLION)

TABLE 2. GLOBAL ANIMAL DIAGNOSTICS MARKET, BY TYPE ($ MILLION)

TABLE 3. GLOBAL ANIMAL THERAPEUTICS MARKET, BY TYPE ($ MILLION)

TABLE 4. ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY ANIMAL TYPE ($ MILLION)

TABLE 5. GLOBAL COMPANION ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY GEOGRAPHY ($ MILLION)

TABLE 6. ANIMAL THERAPEUTICS AND DIAGNOSTICS CATTLE MARKET, BY GEOGRAPHY ($ MILLION)

TABLE 7. ANIMAL THERAPEUTICS AND DIAGNOSTICS PIGS MARKET, BY GEOGRAPHY ($ MILLION)

TABLE 8. ANIMAL THERAPEUTICS AND DIAGNOSTICS POULTRY MARKET, BY GEOGRAPHY ($ MILLION)

TABLE 9. ANIMAL THERAPEUTICS AND DIAGNOSTICS SHEEP MARKET, BY GEOGRAPHY ($ MILLION)

TABLE 10. NORTH AMERICA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY PRODUCT ($ MILLION)

TABLE 11. NORTH AMERICA ANIMAL DIAGNOSTICS MARKET, BY TYPE ($ MILLION)

TABLE 12. NORTH AMERICA ANIMAL THERAPEUTICS MARKET, BY TYPE ($ MILLION)

TABLE 13. NORTH AMERICA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY ANIMAL TYPE ($ MILLION)

TABLE 14. NORTH AMERICA COMPANION ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY ANIMAL TYPE ($ MILLION)

TABLE 15. NORTH AMERICA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY COUNTRY ($ MILLION)

TABLE 16. EUROPE ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY PRODUCT ($ MILLION)

TABLE 17. EUROPE ANIMAL DIAGNOSTICS MARKET, BY TYPE ($ MILLION)

TABLE 18. EUROPE ANIMAL THERAPEUTICS MARKET, BY TYPE ($ MILLION)

TABLE 19. EUROPE ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY ANIMAL TYPE ($ MILLION)

TABLE 20. EUROPE COMPANION ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY ANIMAL TYPE ($ MILLION)

TABLE 21. EUROPE ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY COUNTRY ($ MILLION)

TABLE 22. ASIA-PACIFIC ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY PRODUCT ($ MILLION)

TABLE 23. ASIA-PACIFIC ANIMAL DIAGNOSTICS MARKET, BY TYPE ($ MILLION)

TABLE 24. ASIA-PACIFIC ANIMAL THERAPEUTICS MARKET, BY TYPE ($ MILLION)

TABLE 25. ASIA-PACIFIC ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY ANIMAL TYPE ($ MILLION)

TABLE 26. ASIA-PACIFIC COMPANION ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY ANIMAL TYPE ($ MILLION)

TABLE 27. ASIA-PACIFIC ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY COUNTRY ($ MILLION)

TABLE 28. LAMEA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY PRODUCT ($ MILLION)

TABLE 29. LAMEA ANIMAL DIAGNOSTICS MARKET, BY TYPE ($ MILLION)

TABLE 30. LAMEA ANIMAL THERAPEUTICS MARKET, BY TYPE ($ MILLION)

TABLE 31. LAMEA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY ANIMAL TYPE ($ MILLION)

TABLE 32. LAMEA COMPANION ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY ANIMAL TYPE ($ MILLION)

TABLE 33. LAMEA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY COUNTRY ($ MILLION)

TABLE 34. BAYER: COMPANY SNAPSHOT

TABLE 35. BAYER: OPERATING SEGMENTS

TABLE 36. ELI LILLY: COMPANY SNAPSHOT

TABLE 37. ELI LILLY: OPERATING SEGMENTS

TABLE 38. BOEHRINGER INGELHEIM: COMPANY SNAPSHOT

TABLE 39. BOEHRINGER INGELHEIM: OPERATING SEGMENTS

TABLE 40. MERCK: COMPANY SNAPSHOT

TABLE 41. MERCK: OPERATING SEGMENTS

TABLE 42. ZOETIS: COMPANY SNAPSHOT

TABLE 43. ZOETIS: OPERATING SEGMENTS

TABLE 44. CEVA SANT ANIMALE: COMPANY SNAPSHOT

TABLE 45. CEVA SANT ANIMALE: OPERATING SEGMENTS

TABLE 46. SANOFI: COMPANY SNAPSHOT

TABLE 47. SANOFI: OPERATING SEGMENTS

TABLE 48. NUTRECO: COMPANY SNAPSHOT

TABLE 49. NUTRECO: OPERATING SEGMENTS

TABLE 50. VIRBAC: COMPANY SNAPSHOT

TABLE 51. VIRBAC: OPERATING SEGMENTS

LIST OF FIGURES

FIGURE 1. GLOBAL PATIENT MECHANICAL LIFT HANDLING EQUIPMENT MARKET: SEGMENTATION

FIGURE 2. TOP INVESTMENT POCKETS: GLOBAL ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY ANIMAL TYPE

FIGURE 3. U.S. ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, 2014-2022

FIGURE 4. CANADA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, 2014-2022

FIGURE 5. MEXICO ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, 2014-2022

FIGURE 6. GERMANY ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, 2014-2022

FIGURE 7. FRANCE ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, 2014-2022

FIGURE 8. UK ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, 2014-2022

FIGURE 9. ITALY ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, 2014-2022

FIGURE 10. REST OF EUROPE ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, 2014-2022

FIGURE 11. JAPAN ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, 2014-2022

FIGURE 12. CHINA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, 2014-2022

FIGURE 13. AUSTRALIA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, 2014-2022

FIGURE 14. INDIA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, 2014-2022

FIGURE 15. SOUTH KOREA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, 2014-2022

FIGURE 16. TAIWAN ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, 2014-2022

FIGURE 17. REST OF ASIA-PACIFIC ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, 2014-2022

FIGURE 18. BRAZIL ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, 2014-2022

FIGURE 19. TURKEY ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, 2014-2022

FIGURE 20. VENEZUELA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, 2014-2022

FIGURE 21. SAUDI ARABIA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, 2014-2022

FIGURE 22. REST OF LAMEA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, 2014-2022

FIGURE 23. BAYER: REVENUE, BY YEAR ($MILLION)

FIGURE 24. BAYER: REVENUE, BY SEGMENT, 2015 (%)

FIGURE 25. BAYER: REVENUE, BY GEOGRAPHY, 2015 (%)

FIGURE 26. ELI LILLY: REVENUE, BY YEAR ($MILLION)

FIGURE 27. ELI LILLY: REVENUE, BY SEGMENT, 2015 (%)

FIGURE 28. ELI LILLY: REVENUE, BY GEOGRAPHY, 2015 (%)

FIGURE 29. BOEHRINGER INGELHEIM: REVENUE, BY YEAR ($MILLION)

FIGURE 30. BOEHRINGER INGELHEIM: REVENUE, BY SEGMENT, 2015 (%)

FIGURE 31. BOEHRINGER INGELHEIM: REVENUE, BY GEOGRAPHY, 2015 (%)

FIGURE 32. MERCK: REVENUE, BY YEAR ($MILLION)

FIGURE 33. MERCK: REVENUE, BY SEGMENT, 2015 (%)

FIGURE 34. MERCK: REVENUE, BY GEOGRAPHY, 2015 (%)

FIGURE 35. ZOETIS: REVENUE, BY YEAR ($MILLION)

FIGURE 36. ZOETIS: REVENUE, BY SEGMENT, 2015 (%)

FIGURE 37. ZOETIS: REVENUE, BY GEOGRAPHY, 2015 (%)

FIGURE 38. CEVA SANT ANIMALE: REVENUE, BY YEAR ($MILLION)

FIGURE 39. CEVA SANT ANIMALE: REVENUE, BY SEGMENT, 2015 (%)

FIGURE 40. CEVA SANT ANIMALE: REVENUE, BY GEOGRAPHY, 2015 (%)

FIGURE 41. SANOFI: REVENUE, BY YEAR ($MILLION)

FIGURE 42. SANOFI: REVENUE, BY SEGMENT, 2015 (%)

FIGURE 43. SANOFI: REVENUE, BY GEOGRAPHY, 2015 (%)

FIGURE 44. NUTRECO: REVENUE, BY YEAR ($MILLION)

FIGURE 45. NUTRECO: REVENUE, BY SEGMENT, 2015 (%)

FIGURE 46. NUTRECO: REVENUE, BY GEOGRAPHY, 2015 (%)

FIGURE 47. VIRBAC: REVENUE, BY YEAR ($MILLION)

FIGURE 48. VIRBAC: REVENUE, BY SEGMENT, 2015 (%)

FIGURE 49. VIRBAC: REVENUE, BY GEOGRAPHY, 2015 (%)